RM LAW Announces Investigation of MiMedx Group, Inc.

BERWYN, Pa., Feb. 20, 2018 /PRNewswire/ -- RM LAW, P.C. has commenced an investigation into potential securities law violations by certain officers of MiMedx Group, Inc. ("MiMedx" or the "Company") (NASDAQ: MDXG).

If you purchased shares of MiMedx and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (844) 291-9299 or to sign up online, click here.

On February 20, 2018, before the market opened, MiMedx issued a press release disclosing the delay in the release of its fourth quarter 2017 financial results as its Audit Committee is conducting "an internal investigation into current and prior-period matters relating to allegations regarding certain sales and distribution practices at the Company."  MiMedx is "also reviewing, among other items, the accounting treatment of certain distributor contracts."

As a result of the disclosure, MiMedx stock price declined more than $4.50 per share on intraday trading on February 20, 2018.

For more information regarding this, please contact RM LAW, P.C.  (Richard A. Maniskas, Esquire) toll-free at (844) 291-9299 or by email at rm@maniskas.com or click here.   For more information about class action cases in general or to learn more about RM LAW, P.C. please visit our website by clicking here. 

RM LAW, P.C. is a national shareholder litigation firm.  RM LAW, P.C. is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.

CONTACT: RM LAW, P.C.
Richard A. Maniskas, Esquire
1055 Westlakes Dr., Ste. 300
Berwyn, PA 19312
484-324-6800
844-291-9299
rm@maniskas.com

View original content with multimedia:http://www.prnewswire.com/news-releases/rm-law-announces-investigation-of-mimedx-group-inc-300601454.html

SOURCE RM LAW, P.C.